Page 98 - Read Online
P. 98

Page 196                  Ma et al. J Transl Genet Genom 2022;6:179-203  https://dx.doi.org/10.20517/jtgg.2021.48

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Flitcroft DI, He M, Jonas JB, et al. IMI - Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic
                    studies. Invest Ophthalmol Vis Sci 2019;60:M20-30.  DOI  PubMed  PMC
               2.       Ohno-Matsui K, Wu PC, Yamashiro K, et al. IMI pathologic myopia. Invest Ophthalmol Vis Sci 2021;62:5.  DOI  PubMed  PMC
               3.       Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through
                    2050. Ophthalmology 2016;123:1036-42.  DOI  PubMed
               4.       Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal
                    neovascularization: an evidence-based systematic review. Am J Ophthalmol 2014;157:9-25.e12.  DOI  PubMed
               5.       Grzybowski A, Kanclerz P, Tsubota K, Lanca C, Saw SM. A review on the epidemiology of myopia in school children worldwide.
                    BMC Ophthalmol 2020;20:27.  DOI  PubMed  PMC
               6.       Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.
                    Ophthalmology 2006;113:1134.e1-11.  DOI  PubMed
               7.       Liang YB, Friedman DS, Wong TY, et al; Handan Eye Study Group. Prevalence and causes of low vision and blindness in a rural
                    chinese adult population: the Handan Eye Study. Ophthalmology 2008;115:1965-72.  DOI
               8.       Jin ZB, Wu J, Huang XF, et al. Trio-based exome sequencing arrests de novo mutations in early-onset high myopia. Proc Natl Acad
                    Sci U S A 2017;114:4219-24.  DOI  PubMed  PMC
               9.       Cai XB, Shen SR, Chen DF, Zhang Q, Jin ZB. An overview of myopia genetics. Exp Eye Res 2019;188:107778.  DOI  PubMed
               10.       Wang J, Li Y, Musch DC, et al. Progression of myopia in school-aged children after COVID-19 home confinement. JAMA
                    Ophthalmol 2021;139:293-300.  DOI  PubMed  PMC
               11.       Zhang X, Cheung SSL, Chan HN, et al. Myopia incidence and lifestyle changes among school children during the COVID-19
                    pandemic: a population-based prospective study. Br J Ophthalmol ;2021:bjophthalmol-2021.  DOI  PubMed  PMC
               12.       Bullimore MA, Brennan NA. Myopia control: why each diopter matters. Optom Vis Sci 2019;96:463-5.  DOI  PubMed
               13.       Xiao O, Guo X, Wang D, et al. Distribution and severity of myopic maculopathy among highly myopic eyes. Invest Ophthalmol Vis
                    Sci 2018;59:4880-5.  DOI  PubMed
               14.       Yan YN, Wang YX, Yang Y, et al. Ten-year progression of myopic maculopathy: the beijing eye study 2001-2011. Ophthalmology
                    2018;125:1253-63.  DOI  PubMed
               15.       Fang Y, Yokoi T, Nagaoka N, et al. Progression of myopic maculopathy during 18-year follow-up. Ophthalmology 2018;125:863-77.
                    DOI  PubMed
               16.       Koh V, Tan C, Tan PT, et al. Myopic Maculopathy and optic disc changes in highly myopic young asian eyes and impact on visual
                    acuity. Am J Ophthalmol 2016;164:69-79.  DOI  PubMed
               17.       Ohno-Matsui K, Kawasaki R, Jonas JB, et al; META-analysis for Pathologic Myopia (META-PM) Study Group. International
                    photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 2015;159:877-83.e7.  DOI  PubMed
               18.       Yan YN, Wang YX, Xu L, Xu J, Wei WB, Jonas JB. Fundus tessellation: prevalence and associated factors: the beijing eye study
                    2011. Ophthalmology 2015;122:1873-80.  DOI  PubMed
               19.       Hayashi K, Ohno-Matsui K, Shimada N, et al. Long-term pattern of progression of myopic maculopathy: a natural history study.
                    Ophthalmology 2010;117:1595-611, 1611.e1.  DOI  PubMed
               20.       Ohno-Matsui K, Lai TY, Lai CC, Cheung CM. Updates of pathologic myopia. Prog Retin Eye Res 2016;52:156-87.  DOI  PubMed
               21.       Wang NK, Lai CC, Chu HY, et al. Classification of early dry-type myopic maculopathy with macular choroidal thickness. Am J
                    Ophthalmol 2012;153:669-77, 677.e1.  DOI  PubMed
               22.       Jonas JB, Holbach L, Panda-Jonas S. Bruch’s membrane thickness in high myopia. Acta Ophthalmol 2014;92:e470-4.  DOI  PubMed
               23.       Du R, Fang Y, Jonas JB, et al. Clinical features of patchy chorioretinal atrophy in pathologic myopia. Retina 2020;40:951-9.  DOI
                    PubMed
               24.       Ohno-Matsui K, Jonas JB, Spaide RF. Macular bruch membrane holes in highly myopic patchy chorioretinal atrophy. Am J
                    Ophthalmol 2016;166:22-8.  DOI  PubMed
   93   94   95   96   97   98   99   100   101   102   103